Overview

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Status:
Recruiting
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the behavioral effects of methamphetamine during maintenance on placebo, duloxetine, methylphenidate and duloxetine combined with methylphenidate using sophisticated human laboratory methods.
Phase:
Phase 1
Details
Lead Sponsor:
Craig Rush
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Dopamine
Duloxetine Hydrochloride
Methamphetamine
Methylphenidate